Back to Search
PATRICK HESKETH, MD
MD
Anesthesiology Physician
NPI: 1194353243IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
72119(TN)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 2020
Research & Publications (20)
Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.
PMID 19066985·Support Care Cancer·2009
3-trial
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
PMID 18758306·J Thorac Oncol·2008
3-trial
Stress-induced chemical detection using flexible metal-organic frameworks.
PMID 18841964·J Am Chem Soc·2008
8-other
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
PMID 17545848·J Thorac Oncol·2007
3-trial
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
PMID 17473660·J Thorac Oncol·2007
3-trial
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
PMID 17545843·J Thorac Oncol·2007
2-rct
Batch fabrication of atomic force microscopy probes with recessed integrated ring microelectrodes at a wafer level.
PMID 17521168·Anal Chem·2007
8-other
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.
PMID 17440682·Invest New Drugs·2007
3-trial
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
PMID 17409984·J Thorac Oncol·2006
3-trial
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
PMID 17409914·J Thorac Oncol·2006
3-trial
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
PMID 18632487·Support Cancer Ther·2006
8-other
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
PMID 16717289·J Clin Oncol·2006
6-review
Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.
PMID 16314401·Ann Oncol·2006
8-other
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.
PMID 16450086·Support Care Cancer·2006
2-rct
Eimeria maxima: the influence of host genotype on parasite reproduction as revealed by quantitative real-time PCR.
PMID 16300767·Int J Parasitol·2006
7-preclinical
Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
PMID 16264934·Nat Clin Pract Oncol·2005
6-review
Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?
PMID 16354308·Clin Lung Cancer·2005
8-other
The influence of immunizing dose size and schedule on immunity to subsequent challenge with antigenically distinct strains of Eimeria maxima.
PMID 16537164·Avian Pathol·2005
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1211 Medical Center Dr
Nashville, TN 37232 - Phone
- (615) 936-7616
Quick Facts
- NPI
- 1194353243
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile